Literature DB >> 18850097

A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.

Paolo Zanotti-Fregonara, Gaia Grassetto, Elif Hindié, Domenico Rubello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18850097     DOI： 10.1007/s00259-008-0963-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  19 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

Review 2.  Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies.

Authors:  Carole A Spencer
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

3.  Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma.

Authors:  G Ronga; M Filesi; G Ventroni; A R Vestri; A Signore
Journal:  Eur J Nucl Med       Date:  1999-11

4.  Which thyroid cancer patients need periodic stimulation tests?

Authors:  Paolo Zanotti-Fregonara; Alexandre Khoury; Françoise Duron; Isabelle Keller; Sophie Christin-Maître; Thierry Kiffel; Marie Elisabeth Toubert; Jean-Yves Devaux; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-14       Impact factor: 9.236

5.  Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.

Authors:  Robert C Smallridge; Shon E Meek; Melissa A Morgan; Geoffrey S Gates; Thomas P Fox; Stefan Grebe; Vahab Fatourechi
Journal:  J Clin Endocrinol Metab       Date:  2006-10-31       Impact factor: 5.958

6.  Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?

Authors:  Elif Hindié; Didier Mellière; Françoise Lange; Iyad Hallaj; Claire de Labriolle-Vaylet; Christian Jeanguillaume; Jacques Lange; Léon Perlemuter; Serge Askienazy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

7.  Scintigraphic visualization of glossal thyroid tissue during the follow-up of thyroid cancer patients.

Authors:  Paolo Zanotti-Fregonara; Elif Hindié; Isabelle Keller; Marie Calzada-Nocaudie; Jean-Yves Devaux
Journal:  Clin Nucl Med       Date:  2007-12       Impact factor: 7.794

8.  Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome.

Authors:  Elif Hindié; Paolo Zanotti-Fregonara; Isabelle Keller; Françoise Duron; Jean-Yves Devaux; Marie Calzada-Nocaudie; Emile Sarfati; Jean-Luc Moretti; Philippe Bouchard; Marie-Elisabeth Toubert
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

9.  Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma.

Authors:  A J Brendel; B Lambert; M Guyot; R Jeandot; H Dubourg; P Roger; S Wynchauk; G Manciet; G Lefort
Journal:  Eur J Nucl Med       Date:  1990

10.  Second primary malignancies in thyroid cancer patients.

Authors:  C Rubino; F de Vathaire; M E Dottorini; P Hall; C Schvartz; J E Couette; M G Dondon; M T Abbas; C Langlois; M Schlumberger
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640
View more
  2 in total

1.  Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation.

Authors:  Daniela Schmidt; Rainer Linke; Michael Uder; Torsten Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-20       Impact factor: 9.236

2.  Diffuse skeletal metastasis and low thyroglobulin level in a pediatric patient with papillary thyroid carcinoma.

Authors:  Seyed Rasoul Zakavi; Narjess Ayati; Jamshid Farahati; Behrooz Davachi
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.